Financial News
Ocugen Inc (NQ: OCGN )
1.300
+0.030
(+2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Headline News about Ocugen Inc
![](https://g.foolcdn.com/editorial/images/656788/fda-blocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_977.jpeg)
![](https://investorplace.com/wp-content/uploads/2020/02/rng-stock.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/10/renn1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/12/eye-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5740.jpeg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600gene.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://www.investors.com/wp-content/uploads/2021/02/Tech-covidmutation-030121-shutt.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_500.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_338.png)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_66.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2622.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_497.png)
![](https://g.foolcdn.com/editorial/images/650888/gettyimages-1296010642.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2617.png)
Ocugen-Partnered Bharat Biotech's COVID-19 Shot Shows 50% Effectiveness In Small Study In India
November 24, 2021
Via Benzinga
Exposures
COVID-19
![](https://g.foolcdn.com/editorial/images/654164/gettyimages-1322901776.jpg)
![](https://g.foolcdn.com/editorial/images/653854/vaccine-vials-2-knocked-over-and-2-standing.jpg)
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen
November 21, 2021
Via The Motley Fool
Exposures
COVID-19
![](https://g.foolcdn.com/editorial/images/653210/doctor-prepares-injection-for-patient.jpg)
![](https://g.foolcdn.com/editorial/images/654119/stethoscope-atop-100-dollar-bills-and-pennies.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://g.foolcdn.com/editorial/images/653136/gettyimages-1219401083.jpg)
![](https://g.foolcdn.com/editorial/images/653506/red-line-going-up-with-a-rocket.jpg)
![](https://investorplace.com/wp-content/uploads/2021/08/growth_h_1600.jpg)
![](https://g.foolcdn.com/editorial/images/653354/gettyimages-1318178022.jpg)
3 Things About Ocugen That Smart Investors Know
November 17, 2021
Via The Motley Fool
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.